Company

GlaxoSmithKline plc

Headquarters: Brentford, United Kingdom

Founded: December 2000

Employees: 90,096

CEO: Ms. Emma N. Walmsley

show_chart LSE: GSK

Market Cap

£83.87 Billion

GBP as of April 1, 2022

US$109.98 Billion

history Market Cap History

Company Description

GlaxoSmithKline PLC, better known as GSK, is a pharmaceutical company. GSK manufactures products for major disease areas such as asthma, cancer, infections, diabetes, and mental health, and it also has a portfolio of vaccines. Operating in more than 115 countries, GSK is also engaged in the consumer healthcare business in oral health, pain relief, respiratory, nutrition/gastro-intestinal, and skin health categories.

GlaxoSmithKline plc market capitalization over time

Evolution of GlaxoSmithKline plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of GlaxoSmithKline plc

Detailed Description

GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Wikipedia Introduction

GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in London, England. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham,[n 1] GSK was the world's sixth largest pharmaceutical company according to Forbes as of 2019, after Pfizer, Novartis, Roche, Sanofi, and Merck & Co. GSK is the tenth largest pharmaceutical company and #296 on the 2019 Fortune 500, ranked behind other pharmaceutical companies including China Resources, Johnson & Johnson, Roche, Sinopharm, Pfizer, Novartis, Bayer, Merck, and Sanofi. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of August 2016, it had a market capitalisation of £81 billion (about US$107 billion), the fourth largest on the London Stock Exchange. It has a secondary listing on the New York Stock Exchange. The company developed the first malaria vaccine, RTS,S, which it said in 2014 it would make available for five percent above cost. Legacy products developed at GSK include several listed in the World Health Organization's List of Essential Medicines, such as amoxicillin, mercaptopurine, pyrimethamine, and zidovudine. In 2012, under prosecution by the United States Department of Justice (DoJ) based on combined investigations of the Department of Health and Human Services (HHS-OIG), FDA and FBI, primarily concerning sales and marketing of the drugs Avandia, Paxil, and Wellbutrin, GSK pleaded guilty to promotion of drugs for unapproved uses, failure to report safety data, and kickbacks to physicians in the United States and agreed to pay a US$3 billion (£1.9bn) settlement. It was the largest health-care fraud case to date in the US and the largest settlement by a drug company.

Source: Wikipedia, retrieved on March 31, 2022, 8:41 p.m.

Best-Selling Downloads - UK

FTSE 350 Companies Excel Download $24.90
Top 1300 UK Companies [FTSE All-Share + FTSE AIM All-Share] – Excel Download $59.90
580 Unicorn Startup Companies – Excel Spreadsheet $29.90

Save tens of hours in 2 minutes!

Product & Services

Pharmaceuticals, vaccines, oral healthcare, nutritional products, over-the-counter medicines

Key People

Jonathan Symonds (Chairperson) Emma Walmsley (CEO)

Financials

Revenue: GB£34.114 billion (2021)

Operating income: GB£6.201 billion (2021)

Net income: GB£5.096 billion (2021)


Total assets: GB£79.103 billion (2021)

Total equity: GB£21.342 billion (2021)

Stocks & Indices

GlaxoSmithKline plc has the following listings and related stock indices.


Stock: LSE: GSK

Stock: BCBA: GSK

Stock: BMV: GSKN

Stock: FSX: GS7

Stock: OTC: GLAXF

Stock: XETR: GS7

Stock: NYSE: GSK

Details

Headquarters:

980 Great West Road

Brentford, TW8 9GS

United Kingdom

Phone: 44 20 8047 5000